Smoking cessation: an economic analysis and review of varenicline
Michele A FaulknerCreighton University School of Pharmacy and Health Professions, Omaha, NE, USAAbstract: Despite efforts to decrease tobacco use, smoking continues to be a leading cause of preventable morbidity and premature death. The associated economic burden is substantial, both in the form of...
Saved in:
Main Author: | Michele A Faulkner (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2009-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Pharmacological Basis of the Clinical Efficacy of Varenicline Used to Facilitate Smoking Cessation
by: S. R. Gilyarevskiy
Published: (2019) -
A cost-effectiveness analysis of varenicline for smoking cessation using data from the EAGLES trial
by: Baker CL, et al.
Published: (2018) -
An integrated approach to pharmacotherapy in smoking cessation: the role of varenicline, bupropion, cytisine, and nicotine replacement therapy
by: Kacper Więcław, et al.
Published: (2023) -
Using cost-effectiveness analysis to support policy change: varenicline and nicotine replacement therapy for smoking cessation in Jordan
by: Saba Madae'en, et al.
Published: (2020) -
Insula deep rTMS and varenicline for smoking cessation: A randomized control trial study protocol
by: Christine Ibrahim, et al.
Published: (2022)